List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 35 studies with search of:   "Hemangiosarcoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Bevacizumab in Treating Patients With Angiosarcoma
Condition: Sarcoma
Intervention: Drug: bevacizumab
2 Recruiting Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery
Condition: Sarcoma
Intervention: Drug: paclitaxel
3 Active, not recruiting Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery
Conditions: Childhood Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Interventions: Drug: celecoxib;   Procedure: adjuvant therapy;   Procedure: radiation therapy
4 Recruiting Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Conditions: Childhood Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Procedure: observation;   Procedure: radiation therapy;   Procedure: therapeutic conventional surgery
5 Recruiting Monoclonal Antibody IMC-A12 and Doxorubicin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Conditions: Adult Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Interventions: Drug: cixutumumab;   Drug: doxorubicin hydrochloride
6 Active, not recruiting Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Condition: Tumor
Interventions: Drug: belinostat;   Drug: 5-Fluorouracil (5-FU)
7 Recruiting Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Conditions: Solid Tumor;   Lymphoma
Intervention: Drug: belinostat
8 Completed Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Condition: Life Threatening Diseases
Intervention: Drug: Imatinib mesylate
9 Active, not recruiting Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
Conditions: Ovarian Cancer;   Sarcoma
Intervention: Drug: sorafenib tosylate
10 Active, not recruiting Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: ifosfamide
11 Completed Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma
Conditions: Childhood Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Intervention: Drug: imatinib mesylate
12 Active, not recruiting Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Ovarian Cancer;   Sarcoma
Intervention: Drug: temozolomide
13 Recruiting Radiation Therapy in Treating Patients Who Have Undergone Surgery for Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet
Condition: Sarcoma
Interventions: Procedure: adjuvant therapy;   Procedure: radiation therapy
14 Completed Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Drug: soblidotin
15 Active, not recruiting Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
Condition: Sarcoma
Intervention: Drug: sorafenib tosylate
16 Recruiting Pazopanib in Treating Patients With Metastatic Soft Tissue Sarcoma That Has Relapsed or Not Responded to Treatment
Conditions: Endometrial Cancer;   Kidney Cancer;   Metastatic Cancer;   Ovarian Cancer;   Peripheral Nervous System Neoplasm;   Sarcoma;   Small Intestine Cancer
Interventions: Drug: pazopanib hydrochloride;   Drug: placebo
17 Active, not recruiting Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Drug: exatecan mesylate
18 Active, not recruiting Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: Brain and Central Nervous System Tumors;   Endometrial Cancer;   Gastrointestinal Stromal Tumor;   Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Intervention: Drug: trabectedin
19 Active, not recruiting Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Kidney Cancer;   Ovarian Cancer;   Pheochromocytoma;   Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: filgrastim;   Drug: ifosfamide;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: isolated perfusion;   Procedure: radiation therapy
20 Active, not recruiting Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors
Conditions: Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: dactinomycin;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Drug: etoposide;   Drug: filgrastim;   Drug: ifosfamide;   Drug: vincristine sulfate;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy

Previous Page Studies Shown (1-20) Next (21-35)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services